Early detection of highly pathogenic influenza viruses
(Justus Liebig University) Lack of appropriate drugs and vaccines during the influenza A virus pandemic in 2009, the recent Ebola epidemic in West Africa, as well as the ongoing Middle Eastern Respiratory Syndrome-Coronavirus outbreak demonstrates that the world is only insufficiently prepared for global attacks of emerging infectious diseases and that the handling of such threats remains a great challenge. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2015 Category: Infectious Diseases Source Type: news

Liberia: Hope for Ebola Survivors
[New Republic] Following the successful conduct of the Ebola vaccines study in Liberia under the supervision of the Partnership for Research on Ebola Vaccines Liberia (PREVAIL), a new study which seeks to give hope to Ebola survivors and Liberians in general has been launched in the Liberia. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 22, 2015 Category: African Health Source Type: news

North Korea Claims It Has Found Cure For MERS, Ebola, SARS And AIDS
SEOUL, South Korea (AP) — North Korea says it has succeeded where the greatest minds in science have failed. The authoritarian, impoverished nation better known for pursuing a nuclear program despite global criticism announced Friday it has a drug can prevent and cure MERS, Ebola, SARS and AIDS. The secretive state did not provide proof, and the claim is likely to provoke widespread skepticism. The official Korean Central News Agency said scientists developed Kumdang-2 from ginseng grown from fertilizer mixed with rare-earth elements. According to the pro-North Korea website Minjok Tongshin, the drug was originall...
Source: Science - The Huffington Post - June 19, 2015 Category: Science Source Type: news

North Korea claims 'cure' for Mers, Aids and Ebola
State media say scientists have developed a vaccine for ‘malicious infections’, including the respiratory disease currently sweeping through Asia North Korea says it has succeeded where the greatest minds in science have failed.The authoritarian, impoverished nation announced it has a drug that can prevent and cure Mers, Ebola, Sars and Aids. Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 19, 2015 Category: Science Authors: Associated Press Tags: North Korea Medical research South Korea World news Asia Pacific Science Source Type: news

Study shows how Ebola evolved during the outbreak in West Africa
University of Bristol researchers have played a key role in a new multi-national Ebola study published in Nature. The Ebola virus outbreak in West Africa has been going on for over a year and there have been fears about the speed of virus evolution, and the corresponding effect on vaccines, diagnostics and treatment. The research team used blood samples taken from patients and compared changes in the genetic material of the virus from throughout the outbreak. They were able to show that the outbreak had a single point of origin and predicted that diagnostics and treatment would be effective on the current form of the virus...
Source: University of Bristol news - June 17, 2015 Category: Universities & Medical Training Tags: Research, International; Faculty of Medical and Veterinary Sciences, School of Cellular and Molecular Medicine; Press Release Source Type: news

MERS Outbreak In South Korea Is A 'Wake-Up Call' For All Countries, Says WHO
LONDON (AP)€” The World Health Organization says the spread of a mysterious virus from the Middle East to South Korea doesn't merit being declared a global emergency despite infecting more than 160 people in the biggest outbreak outside the Arabian peninsula. In a statement Wednesday, the U.N. health agency called the epidemic "a wake-up call" and warned all countries to prepare for potential outbreaks of the Middle East respiratory syndrome, or MERS. WHO acknowledged there were still fundamental gaps in its understanding of the disease nearly three years after MERS was first identified. "We really don'...
Source: Science - The Huffington Post - June 17, 2015 Category: Science Source Type: news

Ghana: Health Minister Announces Public Education On Ebola Vaccine Trial
[Ghana Govt.] The Health Minister, Alex Segbefia, has announced that he Ministry will from Wednesday 17th June 2015 begin a nationwide sensitisation programme in Accra on the impending Ebola vaccine clinical trial. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 17, 2015 Category: African Health Source Type: news

Ebola vaccines in limbo expose need for more speed in trials
LONDON (Reuters) - Drugmakers' plans to conduct vast clinical trials to test and hopefully validate the first Ebola vaccines have been thwarted by success in beating back the deadly epidemic in West Africa. (Source: Reuters: Health)
Source: Reuters: Health - June 17, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

There's No Excuse For Our Lack Of A MERS Vaccine, Say Scientists
By Kate Kelland and Ben Hirschler LONDON, June 15 (Reuters) - Three years after the mysterious MERS virus first emerged in humans, scientists and drugmakers say there is no excuse for not having a vaccine that could have protected those now falling sick and dying in South Korea. The facts behind the coronavirus that causes Middle East Respiratory Syndrome (MERS) have been slow to emerge, partly due to a secretive response in Saudi Arabia, which has suffered an outbreak stretching back to 2012. But scientists do know that it is similar to the deadly SARS virus, that it probably originated in bats, that ...
Source: Science - The Huffington Post - June 15, 2015 Category: Science Source Type: news

Ghana: Locals Used As 'Guinea Pigs' in Ebola Trial - Govt
[Al Jazeera] Ghana has suspended a trial for an Ebola vaccine after complaints that locals were being needlessly used as "guinea pigs" in a country currently free of the deadly disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 12, 2015 Category: African Health Source Type: news

Ghana: Ghana Approves Trial of Ebola Vaccine
[Daily Trust] Accra -Despite protests from civil society, the Ghanaian Food and Drugs Authority (FDA) have given the nod for the commencement of Ebola vaccine trial in the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 11, 2015 Category: African Health Source Type: news

Africa: Savsu® Technologies' Specialized Shipping Container Used in Ebola Vaccine Clinical Trials By the World Health Organization
[PR Newswire] Santa Fe, New Mexico -SAVSU Technologies' CryoQ(TM) shipping container is being used by the World Health Organization in Ebola vaccine Phase II clinical trials currently underway in Sierra Leon and Guinea Africa. http://www.who.int/medicines/emp_ebola_q_as/en/ (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 10, 2015 Category: African Health Source Type: news

Ebola Drug Development Slowed by Lack of PatientsEbola Drug Development Slowed by Lack of Patients
Ebola drug development is facing hurdles, but vaccine trials are moving at unprecedented rates, with trials that usually take years to implement getting under way within weeks. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 5, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Soligenix signs collaboration agreement to develop heat stable Ebola vaccine
Soligenix has entered a collaboration agreement with University of Hawaii at Manoa (UH Manoa) and Hawaii Biotech (HBI) to develop a heat stable subunit Ebola vaccine. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 29, 2015 Category: Pharmaceuticals Source Type: news

Africa: WHO Governing Body Ends Session Agreeing 'Landmark' Reforms On Emergency Response
[UN News] The World Health Assembly wrapped up its work today after giving the greenlight for the United Nations World Health Organization (WHO) to reform its emergency and response capacity to better tackle future disease outbreaks like Ebola, and agreeing to address antimicrobial resistance and air pollution, as well as improve access to affordable vaccines and set global nutrition targets. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 27, 2015 Category: African Health Source Type: news

UN health agency governing body ends session agreeing ‘landmark’ reforms on emergency response
The World Health Assembly wrapped up its work today after giving the greenlight for the United Nations World Health Organization (WHO) to reform its emergency and response capacity to better tackle future disease outbreaks like Ebola, and agreeing to address antimicrobial resistance and air pollution, as well as improve access to affordable vaccines and set global nutrition targets. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - May 27, 2015 Category: Global & Universal Source Type: news

Nigeria: Nigeria, Seven Others to Begin Ebola Vaccine Trial
[Guardian] Abuja -Nigeria is one of eight African countries where clinical trials of a vaccine for the Ebola virus disease will soon commence. The others are Liberia, Sierra Leone, Guinea, Cameroun, Ghana, Mali and Senegal. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 20, 2015 Category: African Health Source Type: news

Australian researcher helps with Ebola vaccine trials
An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines. Safe and effective vaccines could help end the ongoing Ebola virus disease epidemic in parts of West Africa and stop future outbreaks of the virus, researchers say. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 19, 2015 Category: Science Source Type: news

Australian researcher helps with Ebola vaccine trials
(Monash University) An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2015 Category: Global & Universal Source Type: news

Liberia: Ebola Trial Vaccine Volunteers to Be Monitored
[New Dawn] The co-investigator of the recent Ebola trial vaccine, Dr. Steven Kennedy, has said volunteers who took the vaccine trial will be monitored for life safety, adding there is a need to keep track of them into their various communities to ensure that they don't experience any kind of problem. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 15, 2015 Category: African Health Source Type: news

Measles vaccine protects against additional diseases
Measles infection induces immune damage that can increase susceptibility to infection for two to three years.Related items from OnMedicaFirst malaria vaccine for children could be recommended for use by autumnMenB vaccine deal agreed in WalesMeningitis B vaccine UK agreement finalisedExperimental Ebola vaccine effective on needle stick doctor Immune organ made from lab cells (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 15, 2015 Category: UK Health Source Type: news

GSK, Emergent and Oxford University commence trial of Ebola vaccine candidates
British drugmaker GlaxoSmithKline (GSK), Emergent BioSolutions and the University of Oxford have commenced a new Phase I study of Ebola vaccine candidates. (Source: Drug Development Technology)
Source: Drug Development Technology - May 14, 2015 Category: Pharmaceuticals Source Type: news

Liberia: Thwarting Measles, Polio - Bomi County to Vaccinate 16,207 Children
[FrontPageAfrica] Tubmanburg -Ebola may have retreated from Liberia but a new outbreak is emerging with the Measles sickness affecting over Eight Counties in the country. At a vaccine campaign in Tubmanburg, Bomi County Saturday, health workers pleaded with mothers to bring their children to be vaccinated. "This is not an Ebola vaccine and it will not kill your child, so baby ma and baby pa please bring your children for the measles vaccine," a health-worker could be heard admonishing health-workers. The Health workers who carried bann (Source: AllAfrica News: Polio)
Source: AllAfrica News: Polio - May 13, 2015 Category: Infectious Diseases Source Type: news

As Ebola disappears, no useful data seen from vaccine trials: WHO
GENEVA (Reuters) - With Ebola nearly stamped out in West Africa, vaccine trials will probably fail to provide enough useful data on how well they protect people against the deadly virus, the World Health Organization (WHO) said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - May 12, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Ebola Crisis of 2014: Are Current Strategies Enough?Ebola Crisis of 2014: Are Current Strategies Enough?
The authors of this brief article suggest three policy changes to address the long-term challenges of ebola virus disease and encourage the development of vaccines and treatments. American Journal of Public Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 12, 2015 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Liberia: UN to Begin Polio, Measles Vaccinations As Ebola Transmissions Plummet
[UN News] United Nations agencies and their partners today announced a massive campaign to vaccinate more than 600,000 children against polio and measles in Liberia as a crucial step towards recovery and the restoration of health services in the West African country, where Ebola transmissions have dwindled in recent weeks. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 11, 2015 Category: African Health Source Type: news

Ebola outbreak is over in Liberia
WHO declares Liberia free of Ebola virus transmissionRelated items from OnMedicaRange of new and costly drugs added to WHO ‘essentials’ listNames for new diseases must not cause offence, WHO saysExperimental Ebola vaccine effective on needle stick doctor Second healthcare worker brought back to England to be monitored for EbolaEbola 'likely to last at least a year' (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 11, 2015 Category: UK Health Source Type: news

UN to begin polio and measles vaccinations as Ebola transmissions plummet in Liberia
United Nations agencies and their partners today announced a massive campaign to vaccinate more than 600,000 children against polio and measles in Liberia as a crucial step towards recovery and the restoration of health services in the West African country, where Ebola transmissions have dwindled in recent weeks. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - May 9, 2015 Category: Global & Universal Source Type: news

My life as an Ebola vaccine guinea pig
Watching the Ebola epidemic on our TV screens last summer, it was impossible not to be struck by the horror that was unfolding. (Source: The Independent - Science)
Source: The Independent - Science - May 1, 2015 Category: Science Tags: Home News Source Type: news

Nigeria: Ebola Vaccine Trial - Nigeria, U.S. Military Set Up Study Center
[Vanguard] Kingsley Omonobi -Nigeria and United State of America (USA) military yesterday commenced collaboration in medical research on a test study of the Ebola vaccine in Abuja. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 1, 2015 Category: African Health Source Type: news

Liberia: Immunization Vaccines Have No Link to Ebola - Health Official
[LINA] The Deputy Program Manager of the Expanded Program on Immunization (EPI) at the Ministry of Health has clarified that the vaccines against measles, polio and mebendazole expected to be administered in May has no connection with the Ebola vaccine trial. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 1, 2015 Category: African Health Source Type: news

Guinea: Vaccination Teams Defeat 'Ebola Effect' in Guinea
[IRIN] Gueckedou -The odds were stacked against Guinea's vaccination teams. The initial side effects of the measles vaccine can easily be mistaken for the first symptoms of hemorraghic fever and a false rumour had spread blaming the distribution of deworming pills in late 2013 for bringing Ebola into the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 30, 2015 Category: African Health Source Type: news

Liberia: UN Resumes Vaccination for Three Million Children
[NEWS] For the first time since the start of the Ebola outbreak in West Africa, thousands of health workers are fanning out across Guinea, Liberia and Sierra Leone in nationwide immunization campaigns with an aim to protect three million children against preventable but potentially deadly diseases such as measles and polio. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 27, 2015 Category: African Health Source Type: news

West Africa: UN Resumes Vaccination Drive for Three Million Children
[UN News] For the first time since the start of the Ebola outbreak in West Africa, thousands of health workers are fanning out across Guinea, Liberia and Sierra Leone in nationwide immunization campaigns with an aim to protect three million children against preventable but potentially deadly diseases such as measles and polio. (Source: AllAfrica News: Polio)
Source: AllAfrica News: Polio - April 27, 2015 Category: Infectious Diseases Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This weeks topics include autism and vaccines, oral insulin and diabetes prevention, management of first time seizures in adults, and long-term effects of Ebola virus infection. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 25, 2015 Category: Pediatrics Source Type: news

UN resumes vaccination drive for three million children in West Africa
For the first time since the start of the Ebola outbreak in West Africa, thousands of health workers are fanning out across Guinea, Liberia and Sierra Leone in nationwide immunization campaigns with an aim to protect three million children against preventable but potentially deadly diseases such as measles and polio. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - April 25, 2015 Category: Global & Universal Source Type: news

Goat plague hits poor farmers in Africa, Asia, wider vaccination needed: FAO
ROME (Thomson Reuters Foundation) - Goat plague, a fast spreading virus, impoverishes millions of small farmers across Africa and Asia, but a campaign to eradicate it has drawn far less support than halting mad cow disease or Ebola, a U.N. veterinary official said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - April 22, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Advancing development of Ebola vaccine trials
As the current Ebola outbreak wanes, scientists have to make the most of every opportunity to prepare for future outbreaks. One such opportunity involves the identification of a safe and effective Ebola vaccine. Texas supercomputers have aided researchers in modelling which types of clinical trials will provide the best information, according to experts. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 21, 2015 Category: Science Source Type: news

UT Austin researchers inform development of Ebola vaccine trials
(University of Texas at Austin, Texas Advanced Computing Center) As the current Ebola outbreak wanes, scientists have to make the most of every opportunity to prepare for future outbreaks. One such opportunity involves the identification of a safe and effective Ebola vaccine. Texas supercomputers have aided researchers in modelling which types of clinical trials will provide the best information. That's according to University of Texas at Austin researchers Steve Bellan and Lauren Meyers, who are studying Ebola vaccine trials with the US Centers for Disease Control and Prevention. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2015 Category: Global & Universal Source Type: news

Apes lack Ebola protection, scientists warn
A vaccine for gorillas and chimpanzees would protect biodiversity and may stop future human epidemics, say experts. (Source: SciDev.Net)
Source: SciDev.Net - April 20, 2015 Category: Global & Universal Source Type: news

West Africa: USAID Announces $126 Million to Rebuild Life-Saving Health Services in Ebola-Affected Countries
[USAID] Washington, DC -U.S. Agency for International Development (USAID) Associate Administrator Mark Feierstein announced plans to spend $126 million to help rebuild West African health systems impacted by the Ebola outbreak at the Global Citizen Concert on the National Mall. The funds will help Liberia, Sierra Leone, and Guinea restart critical health services that stopped due to the Ebola outbreak, including vaccinations, water and sanitation services, prenatal and maternal health care and nutrition, and programs to prevent a (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 20, 2015 Category: African Health Source Type: news

Ebola Vaccine Trial Begins in Sierra Leone
The Centers for Disease Control and Prevention (CDC), in partnership with the Sierra Leone College of Medicine and Allied Health Sciences (COMAHS) and the Sierra Leone Ministry of Health and Sanitation (MoHS), is now enrolling and vaccinating volunteers for the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE). (Source: PHPartners.org)
Source: PHPartners.org - April 17, 2015 Category: Global & Universal Source Type: news

GeoVax and NIH to develop vaccines against Ebola and Marburg viruses
Biotechnology firm GeoVax Labs has signed a research collaboration agreement with the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to develop its vaccines against Ebola and Marburg viruses. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 17, 2015 Category: Pharmaceuticals Source Type: news

Ebola Vaccine Trial Begins In Sierra Leone
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 16, 2015 Category: Journals (General) Source Type: news

Ebola Vaccine Trials - Lest We Forget
(MedPage Today) -- Is it too early for randomized controlled trials for the Ebola vaccine? (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 15, 2015 Category: Pediatrics Source Type: news

Ebola Vaccine Trials -- Lest We Forget
(MedPage Today) -- Is it too early for randomized, controlled trials for the Ebola vaccine? (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 15, 2015 Category: American Health Source Type: news

CDC tests Ebola vaccine in Sierra Leone
Atlanta-based Centers for Disease Control and Prevention is starting a study in Sierra Leone to assess the safety and effectiveness of a new Ebola vaccine among health and other frontline workers. The CDC, in partnership with the Sierra Leone College of Medicine and Allied Health Sciences (COMAHS) and the Sierra Leone Ministry of Health and Sanitation (MoHS), is enrolling and vaccinating volunteers for the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE), the CDC said in a prepared… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 15, 2015 Category: American Health Authors: Carla Caldwell Source Type: news

Merck and NewLink begin Phase II/III trial of Ebola vaccine candidate in Sierra Leone
Merck and NewLink Genetics have initiated the third, late-stage, clinical trial of their Ebola vaccine candidate, rVSV-ZEBOV-GP (V920), in Sierra Leone. (Source: Drug Development Technology)
Source: Drug Development Technology - April 15, 2015 Category: Pharmaceuticals Source Type: news

Ebola Vaccine Trial Begins in Sierra Leone: CDC
Roughly 6,000 health workers will get shots in country hit hard by current outbreak Source: HealthDay Related MedlinePlus Pages: Ebola, Immunization (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 14, 2015 Category: Consumer Health News Source Type: news

Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone
Dateline City: KENILWORTH, N.J. & AMES, Iowa rVSV-ZEBOV-GP (V920) Now Being Studied in Three Key Safety and Efficacy Clinical Trials KENILWORTH, N.J. & AMES, Iowa--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (NASDAQ: NLNK), confirmed today that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has been initiated in Sierra Leone. The vaccine candidate was originally developed by the Public Health Agency of Can...
Source: Merck.com - Corporate News - April 14, 2015 Category: Pharmaceuticals Tags: Ebola Newsroom Corporate News Latest News Source Type: news